Sam Liss will become the next leader of OTD as the University’s chief technology development officer and associate provost.

Five companies started with discoveries in Harvard labs and, with various forms of support, developed impactful solutions that are enhancing our quality of life.

New research out of Harvard Medical School suggests that lithium deficiency may be a key driver of Alzheimer’s disease and a promising target for early diagnosis and treatment. Harvard’s Office of Technology Development has protected the innovations related to this research and is actively seeking industry partners for commercialization to advance these discoveries.

A lab at Harvard T.H. Chan School of Public Health received industry-sponsored research and aims to translate discoveries about a protein that helps regulate metabolism and inflammation into novel therapeutics for obesity, heart disease, and age-related illnesses.